A resurgence of yellow fever disease in multiple African countries has proved difficult to control. Given that we have a highly effective vaccine that confers lifelong immunity, why is yellow fever still a problem? Much of the answer lies in vaccine supply and demand.
No takes yet. Share an insight, caveat, or question.
Alan D.T. Barrett (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: